Myopia; Refractive Error

6

Review clinical trials related to Myopia; Refractive Error. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluation of Novel Spectacles Intended for Myopia Management in a Short-Term Study

The primary objective of this study is to evaluate the visual acuity, wearability, and quality of vision with two novel multifocal glasses designs in habitual myopia control glasses wearers, in a non-dispensing study after short-term wear.

Participants needed: 20
Trial details
Age: 8-15Biological sex: AllType: InterventionalSponsor: Myoptechs, IncUpdated: Apr 1, 2026
Eligibility criteria

8 - 15 years of age, inclusive. [+6]

Current report of active ocular inflammation or infection. [+2]

Status: Recruiting

Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)

The goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance in children. This trial has 3 arms namely, (1) a technical intervention arm, (2) a digital intervention arm, and (3) a control arm. 1. technical intervention - which involves changing of classroom lighting in primary schools to ceiling lights that mimic the spectral composition of sunlight and fluctuates in intensity. Parents of children within that arm will have a sham smart-phone application (s-LightUP) 2. digital intervention - which involves standard classroom lighting and giving parents an interventional smart-phone application (i-LightUP) that will be coupled with their child's light and activity sensor (wrist worn device ). The interventional app will provide individually tailored recommendation based on their children's behaviour (data feedback that is collected from the light and activity monitoring watch). The interventional app would then send reminder prompts/notifications to encourage parents help their children achieve required amounts of myopia-preventive light quantum target set per day. 3. Standard care or control group which involves standard classroom lighting and parents having a sham smart-phone application (s-LightUP) Participants will: * be randomised to receive either no intervention (control group), technical intervention (light intervention that mimics sunlight) or digital intervention (parents having an app that syncs with child's light and activity sensor which will provide feedback to parents to encourage and recommends increment of outdoor activities and hours). * have their myopia progression monitored every 6 monthly and cognitive assessment done once every 3 months over a year. * wear the light and activity sensor watches throughout the 1-year study period as much as possible (minimum 1 week per month) except for wet water activities such as swimming, diving and showering for research data collection purpose.

Participants needed: 396
Trial details
Age: 7-10Biological sex: AllType: InterventionalSponsor: National University of SingaporeUpdated: Sep 23, 2025Locations: 5
Eligibility criteria

Subject must meet all the inclusion criteria below to participate in this study. [+8]

All subjects meeting any of the exclusion criteria at baseline will be excluded... [+4]

Status: Recruiting

Measuring Changes In Choroidal Thickness Induced By Prototype Soft Contact Lenses Worn For 1 Hour

The objective of the study is to evaluate the short-term change in choroidal thickness induced by 3 prototype soft contact lenses for people with myopia.

Participants needed: 20
Trial details
Age: 18-25Biological sex: AllType: InterventionalSponsor: Myoptechs, IncUpdated: Sep 4, 2025Locations: 1
Eligibility criteria

Are 18-25 years of age (inclusive) and have full legal capacity to volunteer; Ha... [+5]

Participating in any concurrent clinical or research study; [+9]

Status: Not yet recruiting

AOSLO-Based Precise Measurement of Retinal Hemodynamics: Development and Application Assessment

Changes in retinal hemodynamics play a key role in the development of various eye diseases. Currently, mainstream hemodynamic evaluation techniques have low resolution and poor measurement accuracy, limiting their widespread application. Adaptive optical laser scanning ophthalmoscopy (AO-SLO) can capture retinal vascular images at the cellular level, offering the potential for high-precision retinal hemodynamic evaluation. This project will: ① innovate the AO-SLO blood flow imaging scanning module and acquisition mode, develop algorithms for extracting spatiotemporal signal features from blood flow images, and achieve quantitative analysis of retinal hemodynamics based on AO-SLO; ② construct an in vitro retinal hemodynamic measurement simulation eye, conduct multidimensional AO-SLO hemodynamic measurements, and establish an intelligent model for precise calibration of retinal hemodynamic parameters; ③ conduct AO-SLO-based retinal hemodynamic studies in high myopia, integrating multi-modal ophthalmic imaging to investigate the patterns of changes in retinal vascular structure and blood flow function in high myopia. Ultimately, a new precision measurement imaging technology platform for retinal hemodynamics will be established.

Participants needed: 120
Trial details
Age: 18-30Biological sex: AllType: ObservationalSponsor: Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUpdated: Jul 4, 2025
Eligibility criteria

Participants must understand the clinical study and voluntarily participate, and... [+2]

Participants with significant refractive media opacity-related conditions (sever... [+5]

Status: Recruiting

Clinical Study of SMILE 4.0-VISULYZE in Correcting Refractive Errors

The aim of this study is to further optimize the surgical input parameters for patients undergoing Small Incision Lenticule Extraction (SMILE) using the regression model established by the SMILE 4.0-VISULYZE system, thereby achieving satisfactory postoperative refractive outcomes. In this study, patients scheduled for SMILE surgery at the investigators' hospital will be divided into two groups: a conventional group, where the input parameters are adjusted based on historical experience according to the patient's refractive error, and a 4.0-VISULYZE group, where the input parameters are optimized using the SMILE 4.0-VISULYZE system. The investigators will compare the postoperative outcomes between the two groups, including uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), spherical power, cylindrical power, spherical equivalent (SE), and the proportions of patients achieving postoperative visual acuity ≥0.8, ≥1.0, and ≥1.2 at 1 day, 10 days, 1 month, 3 months, 6 months, and 1 year post-surgery. Additionally, the investigators will evaluate the proportions of patients with postoperative SE within ±0.50D and ±1.0D, as well as postoperative cylindrical power within ±0.50D and ±1.0D, to assess the efficacy and safety of the SMILE 4.0-VISULYZE system in treating refractive errors.

Participants needed: 600
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: Affiliated Hospital of Nantong UniversityUpdated: May 28, 2025Locations: 2
Eligibility criteria

The diopter is relatively stable (the diopter increases within -0.50D per year f... [+4]

Patients with history of eye surgery and trauma; [+5]

Status: Recruiting

The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.

The goal of this clinical trial is to evaluate the performance of a photorefraction screener in terms of sensibility, sensitivity and accuracy on children aged 3 to 8 y.o. The main objectives of the study are: * Evaluate the performances of the device in comparison with the gold standard, i.e. a tabletop refractometer. * Assess the agreement of the measures obtained with the device with those obtained with the gold standard.

Participants needed: 315
Trial details
Age: 3-8Biological sex: AllType: InterventionalSponsor: Essilor InternationalUpdated: Apr 29, 2025Locations: 2
Eligibility criteria

Aged between 3-8 years when included in the study [+5]

Under myopia control solution that may have an impact on refractive error (such... [+6]